Start saving now
Eligible* commercially insured patients may pay as little as a $25 COPAY FOR UP TO A 90-DAY SUPPLY For first Rx and eligible refills
START SAVING NOW
Not an actual patient.
4 steps to success with VYZULTA
Wash your hands.
Tilt your head back. Gently pull your lower eyelid down to form a pocket for the drop.
Administer 1 drop of VYZULTA into the pocket of the eye(s) being treated.
Keep your eyes closed and gently press on the inner part of the eye for 30-60 seconds to keep VYZULTA in contact with the eye for longer.
Keep the container free of contamination
Avoid touching the tip of the container to the eye or any other surface, including a finger, to avoid contamination of the solution by bacteria. Serious damage to the eye and possible loss of vision may result from using contaminated solutions.
For maximum comfort, take VYZULTA out of the refrigerator and let it come to room temperature before first use.
If you are prescribed VYZULTA, it’s important to take it once daily in the evening. Make this treatment part of your evening routine, as keeping eye pressure low is a lifelong journey.
To keep current with your VYZULTA prescription refills, sign up for reminder texts sent directly to your phone.
Text DROPS to 58129 or scan the QR code.
VYZULTA FAQs
If you wear contact lenses, remove them prior to administering VYZULTA. After administering VYZULTA, wait 15 minutes before reinserting your contact lenses.
If you are using other eye drops in addition to VYZULTA, wait 5 minutes between using each type of eye drop.
Store unopened bottles in the refrigerator. Once a bottle is opened, it may be stored at room temperature for up to 8 weeks. Do not freeze bottles of VYZULTA.
*See full Prescribing Information.
Make VYZULTA part of your evening routine, like brushing your teeth.
Not an actual patient.
-
Join our VYZULTA Community!
Sign up to receive VYZULTA tips, savings, and more
Not an actual patient.
INDICATION
VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%, is used to lower intraocular (eye) pressure in patients with open-angle glaucoma or ocular hypertension.
IMPORTANT SAFETY INFORMATION
- Brown color, or increased brown color, of the iris can occur, which may be permanent. Darkening of the eyelid skin may also occur, which is usually reversible after VYZULTA treatment is discontinued.
- Gradual changes to eyelashes may occur, including increased length, thickness, color, number of eyelashes and/or direction of eyelash growth. These changes may result in a difference in appearance of each eye. These changes are usually reversible after VYZULTA treatment is discontinued.
- Avoid touching the tip of the container to the eye or any other surface, including a finger, in order to avoid contamination of the solution by bacteria. Serious damage to the eye and possible loss of vision may result from using contaminated solutions.
- Tell your doctor immediately about any change in your eye, any eye condition that develops, any sudden change in your vision, any eye side effects, or if you have eye surgery.
- Remove contact lenses before putting VYZULTA in your eyes. Lenses may be reinserted 15 minutes later.
- If you are using other eye drops in addition to VYZULTA, wait 5 minutes between using each type of eye drop.
- The most common side effects seen in studies were eye redness, eye irritation, eye pain, and pain after putting the drops in your eye.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please click here to see full Prescribing Information.
Eligibility criteria/terms and conditions: By using the Bausch + Lomb Access coupon, you confirm that you understand and agree to comply with the following terms and conditions of this offer: This offer is only valid for eligible patients with commercial insurance and eligible uninsured patients. This offer is not valid for any person eligible for reimbursement of prescriptions, in whole or in part, by any federal, state, or other governmental programs, including, but not limited to, Medicare (including Medicare Advantage and Part A, B, and D plans), Medicaid, TRICARE, Veterans Administration or Department of Defense health coverage, CHAMPUS, the Puerto Rico Government Health Insurance Plan, or any other federal or state health care programs. Click here for full eligibility criteria.
INDICATION
VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%, is used to lower intraocular (eye) pressure in patients with open-angle glaucoma or ocular hypertension.
IMPORTANT SAFETY INFORMATION
- Brown color, or increased brown color, of the iris can occur, which may be permanent. Darkening of the eyelid skin may also occur, which is usually reversible after VYZULTA treatment is discontinued.